Research Article
Clinical Features of Primary and Systemic Metastatic Intraocular Lymphomas in Spanish Patients
Table 1
Demographics, timing, and survival in patients with primary and systemic metastatic retinal lymphomas.
| | Subtype n (patients) (%) | PIOL n = 15 | SMRL n = 6 | Total n = 21 | | PVRL n = 11 | PUL n = 4 |
| | Age, years | 60 (12) | 58 (26) | 49.5 (17) | 60 (18) | | Gender (% males) | 5 (45) | 4 (100) | 3 (50) | 12 (57) | | Caucasian, n (%) | 11 (100) | 4 (100) | 3 (50) | 18 (85) | | Bilateral, n (%) | 6 (54) | 0 (0) | 5 (83) | 11 (52) | | Follow-up, months | 25 (59) | 66 (12) | 23 (36) | 30 (60) | | Survival, months | 24 (59) | 60 (6) | 13.5 (20) | 24 (58) | | Survival at final follow-up | 4 (36) | 4 (100) | 1 (16) | 9 (42) | | Survival at 1 year | 9 (81) | 4 (100) | 4 (66) | 17 (80) | | Survival at 5 years | 4/9 (44) | 4/4 (100) | 1/5 (20) | 9/18 (50) | | Time to ocular diagnosis, months | 3 (7) | 9 (20) | 1 (0.5) | 2 (7.2) |
|
|
PVRL, primary vitreo-retinal lymphoma; PIOL, primary intraocular lymphoma; SMRL, systemic metastatic retinal lymphoma; PUL, primary uveal lymphoma.
|
